marimastat has been researched along with fibrin in 1 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bicknell, AB; Lakshminarayanan, K; Layfield, HJ; Mehmi, A; Patel, K; Ravishankar, D; Salim, A; Sonavane, M; Trim, SA; Vaiyapuri, R; Vaiyapuri, S; Vallance, TM; Williams, HF | 1 |
1 other study(ies) available for marimastat and fibrin
| Article | Year |
|---|---|
Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake,
Topics: Animals; Antineoplastic Agents; Antivenins; Binding Sites; Blood Platelets; Catalytic Domain; Collagen; Crotalid Venoms; Crotalus; Drug Repositioning; Erythrocytes; Fibrin; Fibrinolysis; Hemolysis; Humans; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Molecular Docking Simulation; Phenylalanine; Protein Binding; Protein Conformation; Structure-Activity Relationship; Substrate Specificity; Thiophenes | 2020 |